ArticleNeuroscience bulletin2018

Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 : Differential activities of Nav1.7-targeting monoclonal antibodies.

Sangsu Bang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.